Research showed that when PHGDH agonists are administered to patients with refractory epilepsy, both the duration of epileptic seizures and the severity of seizures are reduced, with no adverse reactions such as cognitive impairment reported [40]. Here, PHGDH is linked to Cognitive impairment.